Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): Two multicentre, randomised, double-masked, placebo-controlled phase 3 trials - Lockley, SW; Dressman, MA; Licamele, L; Xiao, C; Fisher, DM; Flynn-Evans, EE; Polymeropoulos, MH (The Lancet, 2015)
10005